AssayIndex
Reports by quarter

Reports submitted in 2024-Q3 · page 5

Nordanalyt Laboratories began contributing. Median purity for the quarter is 99.07 % area, n=464. Read the 2024-Q3 state-of-the-index report →

464 records12 pagesmedian on this page 98.78 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2024-004544HexarelinHYBHYB-2407-N7367PeptideMeter2024-Q399.775.05102.9Buyer-sourced0PASS
AX-2024-004532TirzepatideHYBHYB-2408-V7440Nordanalyt2024-Q398.684.78—Buyer-sourced0PASS
AX-2024-005393GHRP-2PPGPPG-2405-A8164PeptideMeter2024-Q399.876.6794.9Buyer-sourced0PASS
AX-2024-004528ARA-290HYBHYB-2403-B7301Medutest2024-Q399.937.3594.8Buyer-sourced0PASS
AX-2024-004219LiraglutideWWBWWB-2406-R3462Medutest2024-Q399.932.5191.1Laboratory-retained0PASS
AX-2024-005346TirzepatideSIGSIG-2404-6658Nordanalyt2024-Q397.557.85102.9Laboratory-retained0PASS
AX-2024-005321NAD+QSTQST-2402-B5599Janoshik2024-Q397.988.28—Buyer-sourced0PASS
AX-2024-005163N-Acetyl Semax AmideSGNSGN-2407-R9375Janoshik2024-Q398.368.53—Buyer-sourced2FAIL
AX-2024-005048RetatrutideSSASSA-2405-G6509Janoshik2024-Q397.336.92—Buyer-sourced0PASS
AX-2024-005004SemaglutideKPKP-2405-C4939Janoshik2024-Q398.014.67—Buyer-sourced0PASS
AX-2024-004969SemaxMKMMKM-2407-Y4392Nordanalyt2024-Q399.9311.57—Supplier-supplied0PASS
AX-2024-004726RetatrutideHomopeptideHOMO-2405-B3923Medutest2024-Q398.066.3299.3Laboratory-retained0PASS
AX-2024-004586SemaglutideJEEPJEEP-2403-V9444Nordanalyt2024-Q399.502.26107.2Buyer-sourced0PASS
AX-2024-005056PT-141 (Bremelanotide)SSASSA-2403-F6498Janoshik2024-Q398.485.42—Buyer-sourced1FAIL
AX-2024-004967SemaxMKMMKM-2407-Y4392Nordanalyt2024-Q399.6810.99—Buyer-sourced0PASS
AX-2024-004398PT-141 (Bremelanotide)ASYASY-{CAT}-2723PeptideMeter2024-Q399.095.05102.1Buyer-sourced0PASS
AX-2024-005077SS-31 (Elamipretide)SSASSA-2408-G7111Janoshik2024-Q397.976.06101.6Buyer-sourced0FAIL
AX-2024-004513ExenatideHYBHYB-2407-J6692Janoshik2024-Q398.743.9392.0Buyer-sourced0PASS
AX-2024-005050Thymosin α1SSASSA-2407-L6364Janoshik2024-Q398.481.8191.9Buyer-sourced1MARGINAL
AX-2024-004949RetatrutideGGPepsGGPE-2404-K2899PeptideMeter2024-Q398.045.32100.6Buyer-sourced1MARGINAL
AX-2024-004262TirzepatideQYBQYB-2403-T4551PeptideMeter2024-Q399.284.94106.1Buyer-sourced0PASS
AX-2024-005349TirzepatideSIGSIG-2404-6658Janoshik2024-Q397.618.4192.1Buyer-sourced0FAIL
AX-2024-005074SS-31 (Elamipretide)SSASSA-2408-G7111Medutest2024-Q397.906.1392.0Buyer-sourced0FAIL
AX-2024-004886GHRP-6ERPERP-2408-R9378Janoshik2024-Q398.834.8198.3Buyer-sourced1FAIL
AX-2024-004404PT-141 (Bremelanotide)ASYASY-{CAT}-2723Medutest2024-Q399.754.90—Buyer-sourced0PASS
AX-2024-004264TirzepatideQYBQYB-2403-T4551PeptideMeter2024-Q398.994.56—Buyer-sourced0PASS
AX-2024-005110SemaxGL BiochemGLBI-2404-U8284Medutest2024-Q398.847.28—Buyer-sourced1MARGINAL
AX-2024-005022IGF-1 LR3KPKP-2406-K5300Medutest2024-Q398.435.9396.0Buyer-sourced0PASS
AX-2024-004598Enclomiphene citrateTFCTFC-2404-J9626Janoshik2024-Q399.484.13—Buyer-sourced0FAIL
AX-2024-005380AOD-9604PPGPPG-2408-T7905PeptideMeter2024-Q399.492.0498.0Buyer-sourced0PASS
AX-2024-005317NAD+QSTQST-2402-B5599Medutest2024-Q398.249.41106.1Buyer-sourced1FAIL
AX-2024-004953RetatrutideGGPepsGGPE-2404-K2899Janoshik2024-Q397.834.57103.8Buyer-sourced0PASS
AX-2024-004893GonadorelinERPERP-2406-C9933Kestrel2024-Q399.933.7196.1Buyer-sourced0PASS
AX-2024-004728GHRP-6HomopeptideHOMO-2407-T4218VendorInvestigate2024-Q399.546.09106.9Buyer-sourced0PASS
AX-2024-005046RetatrutideSSASSA-2405-G6509PeptideMeter2024-Q397.976.6188.8Buyer-sourced1MARGINAL
AX-2024-004990MK-677 (Ibutamoren mesylate)KPKP-2408-L4573Janoshik2024-Q399.301.96—Buyer-sourced0FAIL
AX-2024-005308SemaglutideBCHBCH-2402-K5559Janoshik2024-Q398.443.4891.3Laboratory-retained0PASS
AX-2024-005254BPC-157BCHBCH-2406-Y4179Janoshik2024-Q398.486.1890.1Buyer-sourced0PASS
AX-2024-004898GonadorelinERPERP-2406-C9933Janoshik2024-Q399.703.5492.1Buyer-sourced0PASS
AX-2024-004514ExenatideHYBHYB-2407-J6692Janoshik2024-Q398.824.25101.0Buyer-sourced0PASS